NO943998L - Farmasöytisk preparat inneholdende cyklosporinderivat - Google Patents

Farmasöytisk preparat inneholdende cyklosporinderivat

Info

Publication number
NO943998L
NO943998L NO943998A NO943998A NO943998L NO 943998 L NO943998 L NO 943998L NO 943998 A NO943998 A NO 943998A NO 943998 A NO943998 A NO 943998A NO 943998 L NO943998 L NO 943998L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
preparation containing
containing cyclosporine
cyclosporine derivative
composition
Prior art date
Application number
NO943998A
Other languages
English (en)
Other versions
NO943998D0 (no
NO315075B1 (no
Inventor
Armin Meinzer
Jacky Francis Vonderscher
Friedrich Richter
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO943998L publication Critical patent/NO943998L/no
Publication of NO943998D0 publication Critical patent/NO943998D0/no
Publication of NO315075B1 publication Critical patent/NO315075B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO19943998A 1992-04-22 1994-10-21 Farmasöytisk preparat inneholdende cyklosporinderivat samt fremgangsmåte for fremstilling av dette NO315075B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929208712A GB9208712D0 (en) 1992-04-22 1992-04-22 Pharmaceutical compositions containing cyclosporin derivates
PCT/EP1993/000955 WO1993020833A1 (en) 1992-04-22 1993-04-20 Pharmaceutical composition containing cyclosporin derivative

Publications (3)

Publication Number Publication Date
NO943998L true NO943998L (no) 1994-10-21
NO943998D0 NO943998D0 (no) 1994-10-21
NO315075B1 NO315075B1 (no) 2003-07-07

Family

ID=10714386

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19943998A NO315075B1 (no) 1992-04-22 1994-10-21 Farmasöytisk preparat inneholdende cyklosporinderivat samt fremgangsmåte for fremstilling av dette

Country Status (22)

Country Link
EP (1) EP0637248B1 (no)
JP (1) JP2818298B2 (no)
KR (2) KR950701227A (no)
AT (1) ATE219940T1 (no)
AU (1) AU672793B2 (no)
CA (1) CA2132740C (no)
CY (1) CY2399B1 (no)
CZ (1) CZ287359B6 (no)
DE (1) DE69332078T2 (no)
DK (1) DK0637248T3 (no)
ES (1) ES2179052T3 (no)
FI (1) FI111130B (no)
GB (1) GB9208712D0 (no)
HU (1) HU218279B (no)
NO (1) NO315075B1 (no)
NZ (1) NZ252681A (no)
PT (1) PT637248E (no)
RU (1) RU2126263C1 (no)
SG (1) SG50692A1 (no)
SK (1) SK282745B6 (no)
UA (1) UA34454C2 (no)
WO (1) WO1993020833A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
DE69307505T2 (de) * 1992-05-13 1997-07-24 Sandoz-Patent-Gmbh, 79539 Loerrach Opthalmische zusammensetzungen enthaltend ein cyclosporin
ES2168271T3 (es) * 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
HUT77283A (hu) 1994-11-03 1998-03-30 Novartis Ag. Egyszerű összetételű, a hatóanyagot biológiailag jól hozzáférhetően tartalmazó, orális alkalmazásra szánt új ciklosporinkészítmény és eljárás az előállítására
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
AU728626B2 (en) * 1997-07-29 2001-01-11 Pharmacia & Upjohn Company Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
ATE265847T1 (de) * 1997-07-29 2004-05-15 Upjohn Co Selbstemulgierbare formulierung enthaltend lipophile verbindungen
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
CA2455288A1 (en) 2001-06-21 2003-01-03 Pfizer Products Inc. Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
US6828301B2 (en) 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
EP2204167A1 (en) * 2009-01-05 2010-07-07 Azad Pharma AG Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
CN102470103B (zh) 2009-07-07 2016-09-07 贝林格尔.英格海姆国际有限公司 用作丙型肝炎病毒蛋白酶抑制剂的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물

Also Published As

Publication number Publication date
ATE219940T1 (de) 2002-07-15
EP0637248B1 (en) 2002-07-03
CA2132740C (en) 2008-01-15
PT637248E (pt) 2002-11-29
DK0637248T3 (da) 2002-10-28
NZ252681A (en) 1996-02-27
HUT71580A (en) 1995-12-28
KR100414853B1 (no) 2004-01-13
NO943998D0 (no) 1994-10-21
DE69332078D1 (de) 2002-08-08
GB9208712D0 (en) 1992-06-10
HU218279B (en) 2000-07-28
CY2399B1 (en) 2004-09-10
AU4261193A (en) 1993-11-18
EP0637248A1 (en) 1995-02-08
SK282745B6 (sk) 2002-12-03
CA2132740A1 (en) 1993-10-28
SG50692A1 (en) 1999-05-25
JPH07505872A (ja) 1995-06-29
NO315075B1 (no) 2003-07-07
HU9403055D0 (en) 1994-12-28
CZ287359B6 (en) 2000-11-15
RU2126263C1 (ru) 1999-02-20
FI944978A0 (fi) 1994-10-21
SK127294A3 (en) 1995-04-12
AU672793B2 (en) 1996-10-17
JP2818298B2 (ja) 1998-10-30
ES2179052T3 (es) 2003-01-16
DE69332078T2 (de) 2002-12-19
RU94046413A (ru) 1996-11-10
WO1993020833A1 (en) 1993-10-28
FI944978A (fi) 1994-10-21
KR950701227A (ko) 1995-03-23
FI111130B (fi) 2003-06-13
UA34454C2 (uk) 2001-03-15
CZ261794A3 (en) 1995-02-15

Similar Documents

Publication Publication Date Title
NO943998L (no) Farmasöytisk preparat inneholdende cyklosporinderivat
CA2099782A1 (fr) Derive de la 5h-pyrrolo[3,4-b] pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent
MX9204379A (es) Microemulsiones de agua en aceite auto-emulsificables, estables, farmaceuticamente aceptables.
NO963242D0 (no) Lipofile bærerpreparater
ES2098180A1 (es) Una composicion farmaceutica a base de compuestos de la clase de la rapamicina.
FI982009A0 (fi) Propofolin mikropisaraformulaatioita
EP0573423A4 (en) Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
ATE143830T1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
CA2039491A1 (en) Stable compositions for parenteral administration and method of making same
MX9204382A (es) Composiciones
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
HUP9900365A2 (hu) N-Aril-1,2,4-triazolin-5-on-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó inszekticid, arachnicid és nematocid készítmények
KR950007857A (ko) 경구투여용 라파마이신 제제
AU7588094A (en) Dihalopropene compound, insecticide/acaricide containing said diahalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound
AU4693489A (en) Stable emulsion formulations of water-insoluable organic pesticides, their use and preparation
ES2169915T3 (es) Composicion utilizable en los ambitos farmaceutico, dietetico y cosmetico.
NO175826C (no) Mikrobiologisk fremgangsmåte ved fremstilling av agrarkjemisk anvendelige virkestoffer, fremstilte forbindelser, anvendelsen av disse og biologisk rene kulturer av sorangium cellulosum som anvendes i fremgangsmåten
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
HUP9702397A3 (en) Preparation of substituted naftaline derivatives, use thereof, insecticide and fungicide compositions containing these compounds as active ingredients
AU8079891A (en) Bile alcohol and drug containing the same as active ingredient
BG97459A (en) Pesticidal formulations
SE9004076D0 (sv) Anvaendning av 10-acetyl-1,8,9-triacetoxi-antracen som antiinflammatoriskst medel vid framstaellning av farmaceutiska och kosmetiska kompositioner
IT8921516A0 (it) Procedimento di microincapsulazione di microorganismi vivi e composizioni farmaceutiche stabili.
FR2655344B1 (fr) Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant.
FR2661677B1 (fr) Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees